We think that Pfizer currently is a better pick compared to Eli Lilly & Company. PFE stock trades at about 5x trailing revenues, compared to around 8x for LLY. Does this gap in Pfizer's valuation make sense? We don't think so. While Pfizer's near term revenue growth has been driven by its Covid-19..
We think that Pfizer currently is a better pick compared to Eli Lilly & Company. PFE stock trades at about 5x trailing revenues, compared to around 8x for LLY. Does this gap in Pfizer's valuation make sense? We don't think so. While Pfizer's near term revenue growth has been driven by its Covid-19..
Share this Article
Recommended